Raffi F - Search Results

1

Patient profiles as organizing HIV clinicians' ART adherence management: a qualitative analysis.

Toupin I, Engler K, Lessard D, Wong L, Lènàrt A, Raffi F, Spire B, Lebouché B. Toupin I, et al. Among authors: raffi f. AIDS Care. 2018 Feb;30(2):207-210. doi: 10.1080/09540121.2017.1360995. Epub 2017 Aug 1. AIDS Care. 2018. PMID: 28764563

2

Adherence to highly active antiretroviral therapies (HAART) in HIV-infected patients: from a predictive to a dynamic approach.

Spire B, Duran S, Souville M, Leport C, Raffi F, Moatti JP; APROCO cohort study group. Spire B, et al. Among authors: raffi f. Soc Sci Med. 2002 May;54(10):1481-96. doi: 10.1016/s0277-9536(01)00125-3. Soc Sci Med. 2002. PMID: 12061483

3

The detection of non-adherence by self-administered questionnaires can be optimized by protease inhibitor plasma concentration determination.

Duran S, Peytavin G, Carrieri P, Raffi F, Ecobichon JL, Pereira E, Cassuto GP, Spire B, Leport C; Antiprotease Cohort (APROCO) study group. Duran S, et al. Among authors: raffi f. AIDS. 2003 May 2;17(7):1096-9. doi: 10.1097/00002030-200305020-00025. AIDS. 2003. PMID: 12700466

4

Impact of early versus late adherence to highly active antiretroviral therapy on immuno-virological response: a 3-year follow-up study.

Carrieri MP, Raffi F, Lewden C, Sobel A, Michelet C, Cailleton V, Chêne G, Leport C, Moatti JP, Spire B; APROCO study group. Carrieri MP, et al. Among authors: raffi f. Antivir Ther. 2003 Dec;8(6):585-94. doi: 10.1177/135965350300800606. Antivir Ther. 2003. PMID: 14760892

5

Indinavir plasma concentration and adherence score are codeterminant of early virologic response in HIV-infected patients of the APROCO cohort.

Duval X, Mentré F, Lamotte C, Chêne G, Spire B, Dellamonica P, Panhard X, Salmon D, Raffi F, Peytavin G, Leport C; APROCO Study Group. Duval X, et al. Among authors: raffi f. Ther Drug Monit. 2005 Feb;27(1):63-70. doi: 10.1097/00007691-200502000-00013. Ther Drug Monit. 2005. PMID: 15665749 Clinical Trial.

6

Factors associated with nonadherence to highly active antiretroviral therapy: a 5-year follow-up analysis with correction for the bias induced by missing data in the treatment maintenance phase.

Carrieri MP, Leport C, Protopopescu C, Cassuto JP, Bouvet E, Peyramond D, Raffi F, Moatti JP, Chêne G, Spire B. Carrieri MP, et al. Among authors: raffi f. J Acquir Immune Defic Syndr. 2006 Apr 1;41(4):477-85. doi: 10.1097/01.qai.0000186364.27587.0e. J Acquir Immune Defic Syndr. 2006. PMID: 16652057

7

Protopopescu C, Marcellin F, Spire B, Préau M, Verdon R, Peyramond D, Raffi F, Chêne G, Leport C, Carrieri MP. Protopopescu C, et al. Among authors: raffi f. Qual Life Res. 2007 May;16(4):577-91. doi: 10.1007/s11136-006-9151-7. Epub 2007 Feb 1. Qual Life Res. 2007. PMID: 17268929

8

Self-reported side-effects of anti-retroviral treatment among IDUs: a 7-year longitudinal study (APROCO-COPILOTE COHORT ANRS CO-8).

Carrieri MP, Villes V, Raffi F, Protopopescu C, Preau M, Salmon D, Taieb A, Lang JM, Verdon R, Chene G, Spire B; APROCO-COPILOTE ANRS CO-08 Study Group. Carrieri MP, et al. Among authors: raffi f. Int J Drug Policy. 2007 Aug;18(4):288-95. doi: 10.1016/j.drugpo.2007.01.014. Epub 2007 Jun 26. Int J Drug Policy. 2007. PMID: 17689377

9

Prevalence and predictors of deterioration of a trustful patient-provider relationship among HIV-infected persons treated with antiretroviral therapy.

Préau M, Leport C, Villes V, Michelet C, Collin F, Carrieri MP, Ragnaud JM, Taieb A, Raffi F, Spire B; ANRS CO-8 APROCO Study Group. Préau M, et al. Among authors: raffi f. J Acquir Immune Defic Syndr. 2008 Apr 1;47(4):467-71. doi: 10.1097/qai.0b013e31815f3bdc. J Acquir Immune Defic Syndr. 2008. PMID: 18434958

10

Effect of lopinavir/ritonavir monotherapy on quality of life and self-reported symptoms among antiretroviral-naive patients: results of the MONARK trial.

Spire B, Marcellin F, Cohen-Codar I, Flandre P, Boue F, Dellamonica P, Raffi F, Norton M, Van Philippe N, Delfraissy JF. Spire B, et al. Among authors: raffi f. Antivir Ther. 2008;13(4):591-9. Antivir Ther. 2008. PMID: 18672538 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

725 results

Search Page

Filters